Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
301 | 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY//LEVOSIMENDAN//PHARMACOLOGY & PHARMACY | 41522 |
1503 | 2 | NEBIVOLOL//CARVEDILOL//BETA BLOCKERS | 7786 |
20614 | 1 | ANTIHYPERTENSIVE PHARMACOTHERAPY//ACE INHIBITION ECHOCARDIOGRAPHY EXERCISES HEMODYNAMICS//ASYSTEMATIC VERTIGO | 476 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ANTIHYPERTENSIVE PHARMACOTHERAPY | authKW | 132422 | 0% | 100% | 2 |
2 | ACE INHIBITION ECHOCARDIOGRAPHY EXERCISES HEMODYNAMICS | authKW | 66211 | 0% | 100% | 1 |
3 | ASYSTEMATIC VERTIGO | authKW | 66211 | 0% | 100% | 1 |
4 | BETA 2 RECEPTOR TOLERANCE | authKW | 66211 | 0% | 100% | 1 |
5 | BETA BLOCKADE ENDURANCE EXERCISE GLYCEROL NEFA | authKW | 66211 | 0% | 100% | 1 |
6 | BETA BLOCKERS NEGATIVE CHRONOTROPIC EFFECT | authKW | 66211 | 0% | 100% | 1 |
7 | BETA1 SELECTIVE BLOCKADE | authKW | 66211 | 0% | 100% | 1 |
8 | BISPROLOL | authKW | 66211 | 0% | 100% | 1 |
9 | BLOOD LACTATE CONCENTRATIONS | authKW | 66211 | 0% | 100% | 1 |
10 | CONGENITAL AND ACQUIRED VITIA | authKW | 66211 | 0% | 100% | 1 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Sport Sciences | 3910 | 21% | 0% | 102 |
2 | Cardiac & Cardiovascular System | 1493 | 23% | 0% | 108 |
3 | Physiology | 1122 | 17% | 0% | 82 |
4 | Pharmacology & Pharmacy | 645 | 23% | 0% | 110 |
5 | Medicine, General & Internal | 340 | 14% | 0% | 65 |
6 | Peripheral Vascular Diseases | 217 | 7% | 0% | 33 |
7 | Primary Health Care | 65 | 1% | 0% | 6 |
8 | Medicine, Research & Experimental | 26 | 4% | 0% | 19 |
9 | Rehabilitation | 18 | 2% | 0% | 8 |
10 | Critical Care Medicine | 16 | 1% | 0% | 7 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | FT BELVOIR COMMUNITY HOSP | 66211 | 0% | 100% | 1 |
2 | HLTH PHYS EDUC RECREAT DANCE BIOKINET | 66211 | 0% | 100% | 1 |
3 | JAMES A TAYLOR CAMPUS HLTH SERV | 66211 | 0% | 100% | 1 |
4 | MED PHARMACOL EXERCISE SCI | 66211 | 0% | 100% | 1 |
5 | SERV EPIDEMIOL EVOLUT CLIN | 66211 | 0% | 100% | 1 |
6 | UNC SPORTS MED | 66211 | 0% | 100% | 1 |
7 | UNIV LEUVENUZ GASTHUISBERG | 66211 | 0% | 100% | 1 |
8 | CARDIOVASC P REHABIL UNIT | 33104 | 0% | 50% | 1 |
9 | HOSP UNIV PONTCHAILLOU | 22069 | 0% | 33% | 1 |
10 | SPORT SCI SOUTH AFRICA | 22069 | 0% | 33% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CLINICAL PHYSIOLOGY | 7555 | 3% | 1% | 12 |
2 | INTERNATIONAL JOURNAL OF SPORTS MEDICINE | 6058 | 4% | 0% | 20 |
3 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 5412 | 5% | 0% | 26 |
4 | HERZ KREISLAUF | 4326 | 2% | 1% | 8 |
5 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 3679 | 4% | 0% | 20 |
6 | AMERICAN JOURNAL OF CARDIOLOGY | 3516 | 8% | 0% | 38 |
7 | ACTA PHYSIOLOGICA SCANDINAVICA | 2709 | 3% | 0% | 15 |
8 | EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY AND OCCUPATIONAL PHYSIOLOGY | 2208 | 1% | 0% | 7 |
9 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 1872 | 3% | 0% | 13 |
10 | JOURNAL OF APPLIED PHYSIOLOGY | 1798 | 5% | 0% | 24 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |